From public IRS filings

DRUGS FOR NEGLECTED DISEASESINITIATIVE NORTH AMERICA INC

NEW YORK, NY · Health Care

EIN (Tax ID): 20-8774179Latest Form 990: 2024IRS ruling year: 2007Find their 990 filing →

Mission

THE DRUGS FOR NEGLECTED DISEASES INITIATIVE (DNDI), NORTH AMERICA SUPPORTS DNDI'S GLOBAL VISION AND MISSION TO DEVELOP NEW DRUGS, OR NEW FORMULATIONS OF EXISTING DRUGS FOR PATIENTS SUFFERING FROM THE MOST NEGLECTED DISEASES. ACTING IN THE PUBLIC INTEREST, DNDI BRIDGES EXISTING R&D GAPS IN ESSENTIAL DRUGS FOR THESE DISEASES BY INITIATING AND COORDINATING DRUG R&D PROJECTS IN COLLABORATION WITH THE INTERNATIONAL RESEARCH COMMUNITY, THE PUBLIC SECTOR, THE PHARMACEUTICAL INDUSTRY, AND OTHER PARTNERS.

Financials (IRS Form 990)

Total revenue
$6.2M
Total expenses
$6.3M
Total assets
$2.5M
Program expense ratio
8059%

Source: IRS Form 990, tax year 2024.

Who funds DRUGS FOR NEGLECTED DISEASESINITIATIVE NORTH AMERICA INC

$4.8M in foundation grants on record from 11 funders — from IRS 990 grant line items.

Leadership

DARIN PORTNOY — NORTH AMERICA DIRECTOR (Principal officer)

Is this your organization?

See which foundations fund organizations like yours — Kindora matches your programs against funders' actual grant histories.

Find your funders